ID   CTC-MCC-41.5B
AC   CVCL_F0X8
SY   Circulating Tumor Cells-Metastatic Colon Cancer-41.5B
RX   PubMed=30374140;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=30374140).
CC   Donor information: Established at the third relapse of the patient from which CTC-MCC-41 (Cellosaurus=CVCL_0I26) was established (PubMed=30374140).
CC   Derived from site: Metastatic; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0I26 ! CTC-MCC-41
OI   CVCL_F0X6 ! CTC-MCC-41.4
OI   CVCL_F0X7 ! CTC-MCC-41.5A
OI   CVCL_F0X9 ! CTC-MCC-41.5C
OI   CVCL_F0XA ! CTC-MCC-41.5D
OI   CVCL_F0XB ! CTC-MCC-41.5E
OI   CVCL_F0XC ! CTC-MCC-41.5F
OI   CVCL_F0XD ! CTC-MCC-41.5G
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
RX   PubMed=30374140; DOI=10.1038/s41598-018-34365-z; PMCID=PMC6206091;
RA   Soler, Alexandra
RA   Cayrefourcq, Laure
RA   Mazard, Thibault
RA   Babayan, Anna
RA   Lamy, Pierre-Jean
RA   Assou, Said
RA   Assenat, Eric
RA   Pantel, Klaus
RA   Alix-Panabieres, Catherine
RT   "Autologous cell lines from circulating colon cancer cells captured
RT   from sequential liquid biopsies as model to study therapy-driven
RT   tumor changes.";
RL   Sci. Rep. 8:15931.1-15931.12(2018).
//